We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Acting Commissioner Ned Sharpless said that the agency will continue to take action against clinics or manufacturers that promote products “ in ways that make them drugs under the law.” Read More
Eli Lilly is asking the Supreme Court to review a lower court’s decision that invalidated a Cialis patent for treatment of prostate gland enlargement. Read More
Researchers believe that they may be on the cusp of the first significant revolution in diabetic care in decades, with a gene therapy candidate that kept diabetes from developing in high-risk patients for an average of two years after just two weeks of IV treatment. Read More
As part of its ongoing enforcement efforts against drug compounders, the FDA plans to move the program’s base of operations from CDER’s Office of the Center Director to the Office of Compliance, Director Janet Woodcock announced Monday. Read More
Official Washington’s patience with the drug industry is wearing thin and the latest sign comes in a letter from eight Republican senators to PhRMA seeking answers—and not excuses—for rising drug prices. Read More
The FDA’s ad police warned a Campbell, Calif.-based company to stop claiming that its prescription diet pill can help patients lose weight three times faster than diet and exercise alone. Read More